NuvOx Pharma has been awarded a Phase I Small Business Innovative Research contract (contract # HHSN268201400045C) for “Development of Molecular Imaging Agents and Methods to Detect High Risk Atherosclerotic Plaque” by the National Heart, Lung, and Blood Institute (NHLBI).Continue reading
Author Archive: AZBio
Utah PADT Office Opened to Enhance Local 3D Printing and ANSYS Sales, Services, and Support
PADT is opening a new local office in Murray, Utah in the Salt Lake City metro area. The office will focus on providing sales, technical support, 3D Printer maintenance, and a meeting space to better serve customers in Utah.Continue reading
TGen and Dell provide critical tools for child-cancer research to National Cancer Institute (NCI)
Dell Genomic Data Analysis Platform provides computational power needed to speed up development of personalized treatment options Continue reading
Arizona State University’s Charles J. Arntzen, PhD named 2014 Arizona Bioscience Researcher of the Year
Charles J. Arntzen, PhD, the founding director of the Biodesign Institute at Arizona State University, has been named the 2014 Arizona Bioscience Researcher of the Year. The award is given annually to the life science researcher in Arizona who has made the most significant contribution to the advancement of knowledge and the understanding of biological processes.Continue reading
Award Winning Pueblo Bioscience Educator Steps into the Spotlight … Again
2010 Arizona Bioscience Educator of the Year Dr. Andrew Lettes, a Pueblo Magnet High School teacher, will be honored as Teacher of the Year as part of the 2014 Governor’s Celebration of Innovation.Continue reading
ASU’s Miles Orchinik, PhD Named Arizona Bioscience Educator of the Year
The Arizona BioIndustry Association has named Miles Orchinik, Ph.D., with the School of Life Sciences at Arizona State University, the 2014 Michael A. Cusanovich Arizona Bioscience Educator of the Year.Continue reading
NuvOx Pharma Receives Patent Covering Core Technology
NuvOx Pharma has been issued a patent covering NuvOx core technology of dodecafluoropentane emulsion. US Patent No. 8,822,549, issued on September 4, 2014, entitled, “Buffered Oxygen Therapeutic,” has claims for buffered formulations of dodecafluoropentane emulsion (DDFPe).
Continue reading
UAMC Trauma Center Chosen for Clinical Study on New Drug that May Improve Function after Acute Spinal Cord Injury
If effective, the new drug could provide a therapeutic option that would offer these patients a greater opportunity to live independently and lessen the impact of this life-altering trauma on them, their family and on society.
Continue reading
Insys Therapeutics, Inc. Named Arizona Bioscience Company of the Year
In recognition of its innovation on behalf of patients, investments in product line development, and its rapidly escalating growth curve, Insys Therapeutics, Inc., of Chandler, Arizona, was named the 2014 Arizona Bioscience Company of the Year by the Arizona Bioindustry Association (AZBio).Continue reading
From Innovation to Investment: Arizona Bioscience Week Has Something For Everyone
What do over 400 life science leaders, Arizona students, innovative companies and accredited investors have in common? They are all participating in Arizona Bioscience Week events and you can too.
Continue reading